Co-Diagnostics, Inc. (CODX)

Price$1.17Cached quote
CODXNasdaq
Loading local price history

Financial charts

Revenue

Net income

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2025202420232022202120202019201820172016
Revenue$622,489$3.9M$6.8M$34.2M$97.9M$74.6M$214,974$39,911$7,662—
Gross profit$400,112$2.9M$2.6M$28.7M$86.3M$58.0M$102,543$30,520$7,360—
Gross margin64.28%74.48%38.57%83.98%88.18%77.75%47.70%76.47%96.06%—
Research & development$19.1M$21.0M$23.0M$17.4M$15.0M$3.2M$1.4M$1.4M$1.0M$731,474
Operating expenses$50.6M$43.0M$45.3M$55.7M$40.2M$16.3M$6.0M$6.1M$4.6M$1.7M
Operating income−$50.2M−$40.1M−$42.7M−$27.0M$46.1M$41.7M−$5.9M−$6.1M−$4.6M−$1.7M
Operating margin−8,058.83%−1,023.75%−626.92%−78.85%47.06%55.93%−2,741.61%−15,328.65%−59,567.57%—
EBITDA−$49.1M−$38.7M−$41.5M−$25.7M$46.4M$41.8M−$5.8M−$6.1M−$4.5M−$1.7M
EBITDA margin−7,881.03%−988.57%−608.86%−75.10%47.40%56.11%−2,710.95%−15,201.45%−58,970.36%—
Net income−$46.9M−$37.6M−$35.3M−$14.2M$36.7M$42.5M−$6.2M−$6.3M−$7.0M−$1.9M
Net profit margin−7,533.62%−961.37%−518.68%−41.61%37.45%56.98%−2,882.00%−15,714.27%−90,827.88%—
Basic EPSper basic share-$35.25-$37.22-$36.00-$13.50$38.10$47.70-$11.10-$15.00-$18.90—
Diluted EPSper diluted share-$35.25-$37.22-$36.00-$13.50$36.90$45.60-$11.10-$15.00-$18.90—

Owners

Reported shareholders

Reference date Jun 30, 2026
ARMISTICE CAPITAL, LLC · 4.84% of listed sharesMURPHY TED · ≈4.59% of listed sharesJANE STREET GROUP, LLC · 1.83% of listed sharesVANGUARD CAPITAL MANAGEMENT LLC · 1.19% of listed sharesPrivate Advisory Group LLC · 0.81% of listed sharesMILLENNIUM MANAGEMENT LLC · 0.66% of listed sharesSUSQUEHANNA INTERNATIONAL GROUP, LLP · 0.64% of listed sharesEgan Dwight H · ≈0.57% of listed sharesGEODE CAPITAL MANAGEMENT, LLC · 0.52% of listed sharesBrown Brian Lee · ≈0.46% of listed sharesVANGUARD FIDUCIARY TRUST CO · 0.41% of listed sharesVirtu Financial LLC · 0.36% of listed sharesUBS Group AG · 0.33% of listed sharesSTATE STREET CORP · 0.30% of listed sharesRENAISSANCE TECHNOLOGIES LLC · 0.26% of listed sharesMurphy Edward L. · ≈0.23% of listed sharesSERBIN RICHARD S · ≈0.22% of listed sharesNELSON JAMES B · ≈0.22% of listed sharesDurenard Eugene · ≈0.22% of listed sharesAbbott Richard David · ≈0.07% of listed shares
4.84%of listed shares
ARMISTICE CAPITAL, LLC236K shares · Jun 30, 2026
View holders
Top 20 reported holders of CODX
Holder% owned
ARMISTICE CAPITAL, LLC
4.84%236K shares
MURPHY TED
≈4.59%224.17K shares
JANE STREET GROUP, LLC
1.83%89.24K shares
VANGUARD CAPITAL MANAGEMENT LLC
1.19%58.28K shares
Private Advisory Group LLC
0.81%39.39K shares
MILLENNIUM MANAGEMENT LLC
0.66%32K shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP
0.64%31.24K shares
Egan Dwight H
≈0.57%27.89K shares
GEODE CAPITAL MANAGEMENT, LLC
0.52%25.58K shares
Brown Brian Lee
≈0.46%22.38K shares
VANGUARD FIDUCIARY TRUST CO
0.41%19.78K shares
Virtu Financial LLC
0.36%17.61K shares
UBS Group AG
0.33%16.09K shares
STATE STREET CORP
0.30%14.8K shares
RENAISSANCE TECHNOLOGIES LLC
0.26%12.5K shares
Murphy Edward L.
≈0.23%11.08K shares
SERBIN RICHARD S
≈0.22%10.75K shares
NELSON JAMES B
≈0.22%10.67K shares
Durenard Eugene
≈0.22%10.67K shares
Abbott Richard David
≈0.07%3.42K shares

Percentages use 4.88M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.

Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about CODX yet. Start the conversation.

Write the first post